Gene-Based Therapeutics for Parkinson’s Disease
<div><p>Parkinson’s disease (PD) is a complex multifactorial disorder that is not yet fully surmised, and it is only when such a disease is tackled on multiple levels simultaneously that we should expect to see fruitful results. Gene therapy is a modern medical practice that theoreticall...
Saved in:
| Main Author: | Karim E. Shalaby (12267224) (author) |
|---|---|
| Other Authors: | Omar M. A. El-Agnaf (8809331) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
by: Abolaji Samson Olagunju (16855185)
Published: (2023) -
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
by: Karim Shalaby (18718678)
Published: (2020) -
Parkinson’s disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes
by: Kalyani B. Karunakaran (12478431)
Published: (2024) -
Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity
by: Vijay Gupta (209146)
Published: (2020) -
Author Correction: Parkinson’s disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes
by: Kalyani B. Karunakaran (12478431)
Published: (2024)